We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
239 hedge funds and large institutions have $2.45B invested in Fate Therapeutics in 2022 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 80 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
85% more call options, than puts
Call options by funds: $2.87M | Put options by funds: $1.55M
27% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 26
3% more funds holding
Funds holding: 233 → 239 (+6)
5% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 80
0.73% less ownership
Funds ownership: 113.36% → 112.63% (-0.73%)
9% less capital invested
Capital invested by funds: $2.69B → $2.45B (-$249M)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
239
Holders Change
+6
Holders Change %
+2.58%
% of All Funds
4.12%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.09%
New
33
Increased
84
Reduced
80
Closed
26
Calls
$2.87M
Puts
$1.55M
Net Calls
+$1.32M
Net Calls Change
+$329K
Top Buyers
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$53.2M |
| 2 |
State Street
Boston,
Massachusetts
|
-$25.6M |
| 3 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$20.4M |
| 4 |
EP
Eversept Partners
New York
|
-$16.9M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$11.6M |
